Patient Factors That Increase Infliximab Clearance and Shorten Half-life in Inflammatory Bowel Disease: A Population Pharmacokinetic Study
Year: 2014
Type: article
Study design: Observational Study
Source: Inflammatory Bowel Diseases
Institutions: Tel Aviv University, Tel Aviv Sourasky Medical Center
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2006783956
